AMEDISYS INC Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020
Cash Flows from Operating Activities:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization (inclusive of depreciation included in cost of service)
Non-cash compensation
Non-cash 401(k) employer match
Amortization and impairment of operating lease right of use assets
(Gain) loss on disposal of property and equipment
Loss on sale of equity method investment
Gain on deconsolidation of joint venture
Write-off of other comprehensive income
Deferred income taxes
Loss on personal care divestiture
Merger termination fee
Equity in (earnings) loss from equity method investments
Amortization of deferred debt issuance costs
Return on equity method investments
Impairment
Changes in operating assets and liabilities, net of impact of acquisitions:
Patient accounts receivable
Other current assets
Operating lease right of use assets
Other assets
Accounts payable
Accrued expenses
Other long-term obligations
Operating lease liabilities

Net cash provided by operating activities
Cash Flows from Investing Activities:
Proceeds from the sale of deferred compensation plan assets
Proceeds from the sale of property and equipment
Purchases of property and equipment
Investments in technology assets
Purchase of investment
Investment in equity method investee
Proceeds from sale of equity method investment
Purchase of cost method investment
Return of investment
Proceeds from personal care divestiture
Acquisitions of businesses, net of cash acquired
Net cash (used in) provided by investing activities

Cash Flows from Financing Activities:
Proceeds from issuance of stock upon exercise of stock options
Proceeds from issuance of stock to employee stock purchase plan
Shares withheld to pay taxes on non-cash compensation
Noncontrolling interest contributions
Noncontrolling interest distributions
Proceeds from sale of noncontrolling interest
Proceeds from borrowings under term loan
Proceeds from borrowings under revolving line of credit
Repayments of borrowings under revolving line of credit
Principal payments of long-term obligations
Debt issuance costs
Provider relief fund advance
Purchase of company stock
Repurchase of noncontrolling interest
Payment of accrued contingent consideration
Purchase of noncontrolling interest
Net cash used in financing activities

Net increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest
Cash Paid For Infinity ZPIC Interest
Cash paid for income taxes, net of refunds received
Note payable issued for software licenses
Accrued contingent consideration
Noncontrolling interest contribution

Comments